Published in Am J Psychiatry on February 01, 2005
Incentives to Decrease Opioid Use - Pilot | NCT04235582
Encouraging Abstinence Behavior in a Drug Epidemic | NCT04927143
Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial. Exp Clin Psychopharmacol (2008) 2.68
Home buprenorphine/naloxone induction in primary care. J Gen Intern Med (2008) 1.67
Drug abstinence: exploring animal models and behavioral treatment strategies. Psychopharmacology (Berl) (2014) 1.52
Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues Clin Neurosci (2007) 1.47
The pharmacological treatment of opioid addiction--a clinical perspective. Eur J Clin Pharmacol (2010) 1.30
The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence. Am J Addict (2010) 1.10
Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin. J Consult Clin Psychol (2007) 1.06
Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases. Brain Res (2009) 1.01
Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options. J Natl Med Assoc (2012) 1.01
The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr (2011) 0.90
Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note. J Addict Res Ther (2013) 0.87
Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research. Pharmacol Rev (2016) 0.87
Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential? Mol Neurobiol (2011) 0.86
Opioid abstinence reinforcement delays heroin lapse during buprenorphine dose tapering. J Appl Behav Anal (2008) 0.84
New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone. Subst Abuse Rehabil (2015) 0.84
Contingency management is efficacious in opioid-dependent outpatients not maintained on agonist pharmacotherapy. Psychol Addict Behav (2013) 0.83
Therapeutic options and challenges for substances of abuse. Dialogues Clin Neurosci (2007) 0.79
Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study. Addiction (2016) 0.78
Methadone plus contingency management or performance feedback reduces cocaine and opiate use in people with drug addiction. Evid Based Ment Health (2005) 0.77
Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria. Trials (2015) 0.77
Anticipatory reward processing among cocaine-dependent individuals with and without concurrent methadone-maintenance treatment: Relationship to treatment response. Drug Alcohol Depend (2016) 0.76
Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users. Am J Addict (2013) 0.76
Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder. J Subst Abuse Treat (2016) 0.75
The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. Am J Psychiatry (2016) 0.75
Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med (2007) 5.68
We don't train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol (2005) 4.71
Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst (2006) 4.01
Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med (2006) 3.64
Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend (2006) 3.61
Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Arch Gen Psychiatry (2009) 3.61
Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 3.52
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (2011) 3.42
Single versus multiple drug focus in substance abuse clinical trials research. Drug Alcohol Depend (2003) 3.19
Brief intervention for hazardous and harmful drinkers in the emergency department. Ann Emerg Med (2008) 3.12
Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? Addiction (2004) 3.06
Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol (2007) 2.98
A brief intervention reduces hazardous and harmful drinking in emergency department patients. Ann Emerg Med (2012) 2.68
Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Intern Med (2007) 2.38
Community program therapist adherence and competence in motivational enhancement therapy. Drug Alcohol Depend (2008) 2.33
Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry (2005) 2.18
Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology (2002) 2.08
Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. Anal Chem (2009) 2.06
Pretreatment brain activation during stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry (2008) 2.04
Contingency management treatments: Reinforcing abstinence versus adherence with goal-related activities. J Consult Clin Psychol (2006) 1.98
Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone. Am J Psychiatry (2014) 1.93
Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. Addiction (2012) 1.93
A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry (2002) 1.86
Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology (Berl) (2005) 1.84
Treatment of heroin dependence with buprenorphine in primary care. Am J Drug Alcohol Abuse (2002) 1.76
Substance abuse vaccines. Ann N Y Acad Sci (2008) 1.74
Consensus statement on office-based treatment of opioid dependence using buprenorphine. J Subst Abuse Treat (2004) 1.70
Mindfulness training for smoking cessation: results from a randomized controlled trial. Drug Alcohol Depend (2011) 1.68
Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos (2003) 1.66
Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry (2006) 1.66
Prescription pain medication dependence. Am J Psychiatry (2011) 1.65
A trial of integrated buprenorphine/naloxone and HIV clinical care. Clin Infect Dis (2006) 1.62
Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage I pilot study. Subst Abus (2009) 1.62
Neuroscience of behavioral and pharmacological treatments for addictions. Neuron (2011) 1.57
Cognitive enhancement as a treatment for drug addictions. Neuropharmacology (2012) 1.54
Treatment outcome predictors for cocaine dependence. Am J Drug Alcohol Abuse (2007) 1.54
Gender differences in adolescent gambling. Ann Clin Psychiatry (2006) 1.51
An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biol Psychiatry (2011) 1.50
The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol (2004) 1.50
Correspondence of motivational enhancement treatment integrity ratings among therapists, supervisors, and observers. Psychother Res (2009) 1.49
Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. Am J Addict (2008) 1.45
Intention-to-treat meets missing data: implications of alternate strategies for analyzing clinical trials data. Drug Alcohol Depend (2002) 1.45
What is usual about "treatment-as-usual"? Data from two multisite effectiveness trials. J Subst Abuse Treat (2008) 1.45
Behavioral health services for women who have breast cancer. J Clin Oncol (2008) 1.45
Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother (2009) 1.45
Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology (Berl) (2006) 1.44
Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China. Addiction (2015) 1.42
Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials (2011) 1.38
Assessing the role of Asp 194 in the transmembrane domains of the α-chain of the high-affinity receptor complex for immunoglobulin E in signal transduction. Mol Immunol (2010) 1.38
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. J Subst Abuse Treat (2007) 1.38
Reasons for dropout from drug abuse treatment: symptoms, personality, and motivation. Addict Behav (2005) 1.36
A cognitive behavioral therapy for alcohol-dependent domestic violence offenders: an integrated substance abuse-domestic violence treatment approach (SADV). Am J Addict (2007) 1.33
Making consent more informed: preliminary results from a multiple-choice test among probation-referred marijuana users entering a randomized clinical trial. J Am Acad Psychiatry Law (2008) 1.33
Quality versus quantity: acquisition of coping skills following computerized cognitive-behavioral therapy for substance use disorders. Addiction (2010) 1.32
A randomized trial adapting contingency management targets based on initial abstinence status of cocaine-dependent patients. J Consult Clin Psychol (2012) 1.32
Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department. Acad Emerg Med (2005) 1.31
Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya. Addiction (2011) 1.29
One small step for manuals: Computer-assisted training in twelve-step facilitation. J Stud Alcohol (2006) 1.29
Challenges in increasing access to buprenorphine treatment for opiate addiction. Am J Addict (2004) 1.29
The cost-effectiveness of four treatments for marijuana dependence. Addiction (2007) 1.29
Choosing a behavioral therapy platform for pharmacotherapy of substance users. Drug Alcohol Depend (2004) 1.28
Therapeutic vaccines for substance dependence. Expert Rev Vaccines (2004) 1.27
Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. J Gen Intern Med (2007) 1.27
D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation. Drug Alcohol Depend (2009) 1.27
Engaging young probation-referred marijuana-abusing individuals in treatment: a pilot trial. Am J Addict (2003) 1.27
Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacol Biochem Behav (2004) 1.26
A methodological analysis of randomized clinical trials of computer-assisted therapies for psychiatric disorders: toward improved standards for an emerging field. Am J Psychiatry (2011) 1.26
Sex differences in brain activation during stress imagery in abstinent cocaine users: a functional magnetic resonance imaging study. Biol Psychiatry (2005) 1.26
Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. Am J Drug Alcohol Abuse (2003) 1.23
Vaccines for cocaine abuse. Hum Vaccin (2009) 1.23
Performance of cocaine dependent individuals and controls on a response inhibition task with varying levels of difficulty. Am J Drug Alcohol Abuse (2007) 1.21
Serious adverse events in randomized psychosocial treatment studies: safety or arbitrary edicts? J Consult Clin Psychol (2008) 1.20
Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerg Drugs (2006) 1.20
Evaluating motivational enhancement therapy adherence and competence among Spanish-speaking therapists. Drug Alcohol Depend (2009) 1.20
Combining cognitive behavioral therapy with contingency management for smoking cessation in adolescent smokers: a preliminary comparison of two different CBT formats. Am J Addict (2007) 1.20
Teaching community program clinicians motivational interviewing using expert and train-the-trainer strategies. Addiction (2010) 1.20
A preliminary study of the neural effects of behavioral therapy for substance use disorders. Drug Alcohol Depend (2011) 1.18
Novel approaches to the treatment of cocaine addiction. CNS Drugs (2005) 1.18
Client satisfaction with three therapies in the treatment of alcohol dependence: results from project MATCH. Am J Addict (2002) 1.16
Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiatry (2002) 1.16
The alliance in motivational enhancement therapy and counseling as usual for substance use problems. J Consult Clin Psychol (2009) 1.16
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
Tailoring cannabis dependence treatment for a diverse population. Addiction (2002) 1.12
Treatment process, alliance and outcome in brief versus extended treatments for marijuana dependence. Addiction (2010) 1.12
The URICA as a measure of motivation to change among treatment-seeking individuals with concurrent alcohol and cocaine problems. Psychol Addict Behav (2002) 1.12
Perfusion abnormalities and decision making in cocaine dependence. Biol Psychiatry (2004) 1.11
The future of vaccines in the management of addictive disorders. Curr Psychiatry Rep (2007) 1.11
A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction (2006) 1.11
Contingency Management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders. Am J Drug Alcohol Abuse (2007) 1.10
Cost-effectiveness of computer-assisted training in cognitive-behavioral therapy as an adjunct to standard care for addiction. Drug Alcohol Depend (2010) 1.10
The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence. Am J Addict (2010) 1.10
Effect of anxiety on treatment presentation and outcome: results from the Marijuana Treatment Project. Psychiatry Res (2010) 1.10
Novel pharmacotherapeutic treatments for cocaine addiction. BMC Med (2011) 1.10